Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Childhood myelodysplasia

B R Agarwal1, Z E Currimbhoy

  • 1Department of Pediatric Hematology and Oncology, B.J. Wadia Hospital for Children, Parel, Bombay.

Indian Pediatrics
|July 1, 1994
PubMed
Summary

Childhood myelodysplasia is a significant hematological malignancy in children, often presenting aggressively. This study highlights its prevalence and potential to transform into acute leukemia, emphasizing the need for early diagnosis and intervention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Myelofibrosis secondary to SLE and its reversal on steroid therapy.

Indian pediatrics·1995
Same author

Treatment of aplastic anemia in children with high dose methyl prednisolone.

Indian pediatrics·1995
Same author

Juvenile chronic myelogenous leukemia: therapeutic trial with interferon alpha 2B.

Indian pediatrics·1995
Same author

Why do hemophiliacs bleed?

Indian pediatrics·1995
Same author

Infected-associated hemophagocytic syndrome.

Indian pediatrics·1995
Same author

Isolated vertebral body relapse of acute lymphoblastic leukemia.

Indian pediatrics·1994

Area of Science:

  • Pediatric Hematology
  • Oncology
  • Clinical Hematology

Background:

  • Childhood myelodysplasia (CMD) is a rare but serious group of bone marrow disorders.
  • Diagnosis relies on specific criteria, such as the French-American-British (FAB) Cooperative Group classification.
  • CMD represents a notable percentage of pediatric hematological malignancies.

Purpose of the Study:

  • To present the clinical and hematological characteristics of childhood myelodysplasia.
  • To analyze the incidence, subtypes, and outcomes of CMD in a pediatric cohort.
  • To investigate the transformation rate of CMD into acute leukemias.

Main Methods:

  • Retrospective analysis of clinical data from 29 children under 12 years old diagnosed with primary myelodysplasia.
  • Classification of cases according to FAB criteria.
  • Evaluation of symptom duration, disease subtypes, evolution to acute leukemia, and survival rates.

Main Results:

  • The study included 29 children (24 males, 5 females) with a median age of 2.5 years.
  • Common subtypes included refractory anemia (15 cases) and chronic myelomonocytic leukemia (10 cases).
  • Five patients progressed to acute myeloid leukemia and four to acute lymphatic leukemia, with a median preleukemic phase of 7 months. Overall survival was poor (5-9 months).

Conclusions:

  • Childhood myelodysplasia is not uncommon and has an aggressive clinical course.
  • CMD frequently evolves into acute leukemia, underscoring the importance of timely diagnosis and management.
  • Further research into effective therapeutic strategies for pediatric myelodysplasia is warranted.

Related Experiment Videos